Presence of large scavenger receptor A-positive cells in systemic circulation: A potential prognostic indicator for idiopathic pulmonary fibrosis, connective tissue disease-associated interstitial lung disease, acute exacerbation and risk factor for acute exacerbation [PDF]
Iwao Emura, Hiroyuki Usuda
openalex +1 more source
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen +2 more
wiley +1 more source
A case of antisynthetase syndrome with interstitial lung disease in pregnancy. [PDF]
Park E +3 more
europepmc +1 more source
Objective Fine particulate matter (PM2.5) is a possible trigger of systemic autoimmune rheumatic diseases (SARDs). We investigated SARDs risk related to long‐term exposure to PM2.5 and its components (ammonium, black carbon, mineral dust, sea salt, nitrate, sulfate, organic matter), the composition of which may affect toxicity.
Mareva Geslin +6 more
wiley +1 more source
Does Cannabis Smoke Cause Interstitial Lung Disease? [PDF]
Bisconti M +14 more
europepmc +1 more source
Objective Vacuoles E1 enzyme X‐linked autoinflammatory somatic syndrome (VEXAS) is a recently identified rare genetic disorder associated with somatic mutations in the UBA1 gene. VEXAS presents with a combination of inflammatory and hematologic manifestations, leading to increased morbidity and mortality.
Arsene Mekinian +111 more
wiley +1 more source
From Chaos to Clarity: Reassessing Interstitial Lung Disease Terminology. [PDF]
Oldham JM, Molyneaux PL.
europepmc +1 more source
Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease [PDF]
Jeong Seok Lee +5 more
openalex +1 more source
B cells and systemic sclerosis interstitial lung disease
Interstitial lung disease is an important complication of systemic sclerosis (SSc‐ILD) with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to FDA‐approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of interstitial lung diseases of other systemic autoimmune ...
Nina Goldman +2 more
wiley +1 more source
Refractory Spontaneous Pneumothorax in Interstitial Lung Disease Under Pirfenidone Treatment. [PDF]
Jeong J, Kang MK.
europepmc +1 more source

